Currie Gavin
Oprichter bij Biosceptre (Aust) Pty Ltd.
Oorsprong van het eerstegraads netwerk van Currie Gavin
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Prescare
 Prescare Miscellaneous Commercial ServicesCommercial Services Prescare provides care services including residential, in-home community care and chaplaincy and pastoral care. It offers residential and dementia care, affordable housing, day therapy centre, respite care and social programs. The company is headquartered in Milton, Australia.
7
| Non-Profit Organization | Miscellaneous Commercial Services | 7 |
Biosceptre (Aust) Pty Ltd.
 Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Currie Gavin via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| GRESHAM TECHNOLOGIES PLC | Packaged Software | President | |
Project Better Energy Ltd.
 Project Better Energy Ltd. Electric UtilitiesUtilities Project Better Energy Ltd. is a British company that generates electric power. The private company is based in Burton-on-Trent, UK. and has subsidiaries in United Kingdom. Project Better Energy was founded in 2012. | Electric Utilities | Director/Board Member | |
Biosceptre International Ltd.
 Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Biotechnology | Chairman Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 4 |
Sectoraal
| Technology Services | 2 |
| Utilities | 2 |
| Health Technology | 2 |
Operationeel
| Director/Board Member | 10 |
| Chairman | 4 |
| President | 1 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sterkste connecties
- Beurs
- Insiders
- Currie Gavin
- Bedrijfsconnecties
